Faisal Khurshid
Stock Analyst at Jefferies
(4.95)
# 118
Out of 4,357 analysts
232
Total ratings
62.1%
Success rate
68.6%
Average return
Main Sectors:
Stocks Rated by Faisal Khurshid
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTCT PTC Therapeutics | Upgraded: Buy | $76 → $85 | $73.80 | +15.18% | 2 | May 27, 2026 | |
| SMMT Summit Therapeutics | Maintained: Hold | $17 | $15.71 | +8.21% | 3 | May 21, 2026 | |
| ONC BeOne Medicines AG | Maintained: Hold | $290 → $333 | $279.68 | +19.06% | 2 | May 21, 2026 | |
| ASND Ascendis Pharma | Maintained: Buy | $290 | $218.82 | +32.53% | 2 | May 6, 2026 | |
| SNDX Syndax Pharmaceuticals | Maintained: Buy | $40 → $37 | $18.85 | +96.29% | 2 | May 1, 2026 | |
| RVMD Revolution Medicines | Maintained: Buy | $140 | $163.68 | -14.47% | 2 | Apr 10, 2026 | |
| VSTM Verastem | Initiated Coverage: Buy | $15 | $4.19 | +258.00% | 1 | Mar 30, 2026 | |
| VRDN Viridian Therapeutics | Rated: Buy | $29 | $16.96 | +70.99% | 1 | Mar 30, 2026 | |
| FDMT 4D Molecular Therapeutics | Initiated Coverage: Buy | $21 | $9.71 | +116.27% | 1 | Mar 30, 2026 | |
| ANIP ANI Pharmaceuticals | Maintained: Buy | $103 → $120 | $76.71 | +56.43% | 14 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $160 | $129.69 | +23.37% | 2 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $228 | $106.03 | +115.03% | 1 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $55 | $34.81 | +58.00% | 1 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $330 | $295.63 | +11.63% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $94 | $95.59 | -1.66% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $11.14 | +61.58% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $118 → $110 | $78.47 | +40.18% | 16 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $33 | $29.13 | +13.29% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $10.44 | +43.68% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $142 | $87.74 | +61.85% | 8 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $21 | $13.09 | +60.49% | 2 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $4 | $6.46 | -38.08% | 3 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 | $17.39 | -30.99% | 8 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $29 → $40 | $27.55 | +45.19% | 11 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 → $9 | $3.53 | +154.96% | 11 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.5466 | - | 17 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $18.01 | - | 11 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.24 | - | 11 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $13.95 | - | 17 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.13 | - | 13 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $94.92 | - | 2 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $70.54 | - | 10 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $2 | $5.65 | -64.60% | 4 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.21 | +147.93% | 17 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $3.46 | -71.10% | 10 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $1.20 | +66.67% | 14 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $74.16 | - | 1 | Jul 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $2.25 | n/a | 7 | Nov 9, 2023 |
PTC Therapeutics
May 27, 2026
Upgraded: Buy
Price Target: $76 → $85
Current: $73.80
Upside: +15.18%
Summit Therapeutics
May 21, 2026
Maintained: Hold
Price Target: $17
Current: $15.71
Upside: +8.21%
BeOne Medicines AG
May 21, 2026
Maintained: Hold
Price Target: $290 → $333
Current: $279.68
Upside: +19.06%
Ascendis Pharma
May 6, 2026
Maintained: Buy
Price Target: $290
Current: $218.82
Upside: +32.53%
Syndax Pharmaceuticals
May 1, 2026
Maintained: Buy
Price Target: $40 → $37
Current: $18.85
Upside: +96.29%
Revolution Medicines
Apr 10, 2026
Maintained: Buy
Price Target: $140
Current: $163.68
Upside: -14.47%
Verastem
Mar 30, 2026
Initiated Coverage: Buy
Price Target: $15
Current: $4.19
Upside: +258.00%
Viridian Therapeutics
Mar 30, 2026
Rated: Buy
Price Target: $29
Current: $16.96
Upside: +70.99%
4D Molecular Therapeutics
Mar 30, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $9.71
Upside: +116.27%
ANI Pharmaceuticals
Mar 25, 2026
Maintained: Buy
Price Target: $103 → $120
Current: $76.71
Upside: +56.43%
Mar 24, 2026
Maintained: Buy
Price Target: $160
Current: $129.69
Upside: +23.37%
Mar 17, 2026
Reiterated: Buy
Price Target: $228
Current: $106.03
Upside: +115.03%
Mar 16, 2026
Initiated Coverage: Buy
Price Target: $55
Current: $34.81
Upside: +58.00%
Mar 15, 2026
Downgraded: Hold
Price Target: $330
Current: $295.63
Upside: +11.63%
Mar 15, 2026
Downgraded: Hold
Price Target: $94
Current: $95.59
Upside: -1.66%
Mar 15, 2026
Initiated Coverage: Buy
Price Target: $18
Current: $11.14
Upside: +61.58%
Mar 15, 2026
Initiated Coverage: Buy
Price Target: $118 → $110
Current: $78.47
Upside: +40.18%
Mar 15, 2026
Downgraded: Hold
Price Target: $33
Current: $29.13
Upside: +13.29%
Mar 15, 2026
Initiated Coverage: Buy
Price Target: $15
Current: $10.44
Upside: +43.68%
Dec 15, 2025
Maintained: Buy
Price Target: $142
Current: $87.74
Upside: +61.85%
Dec 15, 2025
Reiterated: Buy
Price Target: $20 → $21
Current: $13.09
Upside: +60.49%
Nov 7, 2025
Downgraded: Hold
Price Target: $5 → $4
Current: $6.46
Upside: -38.08%
Oct 23, 2025
Reiterated: Hold
Price Target: $12
Current: $17.39
Upside: -30.99%
Oct 22, 2025
Upgraded: Buy
Price Target: $29 → $40
Current: $27.55
Upside: +45.19%
Oct 10, 2025
Initiated Coverage: Buy
Price Target: $7 → $9
Current: $3.53
Upside: +154.96%
Sep 30, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.5466
Upside: -
Sep 30, 2025
Reiterated: Buy
Price Target: n/a
Current: $18.01
Upside: -
Sep 30, 2025
Reiterated: Buy
Price Target: n/a
Current: $4.24
Upside: -
Sep 29, 2025
Reiterated: Buy
Price Target: n/a
Current: $13.95
Upside: -
Sep 25, 2025
Reiterated: Buy
Price Target: n/a
Current: $15.13
Upside: -
Sep 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $94.92
Upside: -
Sep 11, 2025
Reiterated: Buy
Price Target: n/a
Current: $70.54
Upside: -
Aug 18, 2025
Maintained: Buy
Price Target: $4 → $2
Current: $5.65
Upside: -64.60%
Aug 12, 2025
Reiterated: Buy
Price Target: $3
Current: $1.21
Upside: +147.93%
Aug 7, 2025
Reiterated: Hold
Price Target: $1
Current: $3.46
Upside: -71.10%
Aug 7, 2025
Reiterated: Hold
Price Target: $2
Current: $1.20
Upside: +66.67%
Jul 28, 2025
Reiterated: Buy
Price Target: n/a
Current: $74.16
Upside: -
Nov 9, 2023
Reiterated: Hold
Price Target: $2
Current: $2.25
Upside: n/a